National Health Investors, Inc. reported Q1 2026 earnings with net income per diluted share of $0.82, up 10.8% year-over-year, alongside lowered full-year 2026 guidance and key portfolio transactions.
Key takeaways
Net income attributable to common stockholders per diluted share increased 10.8% to $0.82 from $0.74 same quarter prior year.
NAREIT FFO per diluted share rose 7.9% to $1.23 from $1.14 year-over-year.
Normalized FFO per diluted share up 7.0% to $1.23 from $1.15 prior year.
Updated 2026 full-year NAREIT FFO guidance lowered to $4.74-$4.79 per share from $4.94-$4.99.
Executed agreement to sell NHC portfolio of 35 properties for $560.0 million, expected to close July 1, 2026.
Q1 invested capital in SHOP reached $742.5 million, up 106% from prior year period.